Suzanne J Szalay, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 20 Parks Dr, Sherborn, MA 01770 Phone: 508-651-3550 |
Dr. Peter Grey, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 11 Prospect St, Sherborn, MA 01770 Phone: 508-545-1843 Fax: 508-620-1655 |
News Archive
Mitochondria are restless, continually merging and splitting. But contrary to conventional wisdom, the size of these organelles depends on more than fusion and fission, as Berman et al. show. Mitochondrial growth and degradation are also part of the equation.
The Health and Human Services secretary is testifying before the House Energy and Commerce Committee today, as critics question her leadership of the department.
Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that it has initiated a Phase 1 clinical study of HTL9936, the first fully selective muscarinic M1 receptor agonist to enter clinical development. HTL9936 is an orally available, small molecule drug candidate discovered using the Heptares GPCR structure-based drug design platform.
When the pandemic hit the U.S. in early 2020, many routine activities came to a halt.
› Verified 9 days ago